79 related articles for article (PubMed ID: 11244515)
1. Further insights into coronary debulking: the EUROCARE trial of directional atherectomy and the PACT trial of pullback atherectomy.
Thury A; Van Langenhove G; Wardeh AJ; Foley DP; Serruys PW
Semin Interv Cardiol; 2000 Dec; 5(4):185-92. PubMed ID: 11244515
[TBL] [Abstract][Full Text] [Related]
2. Carvedilol for prevention of restenosis after directional coronary atherectomy : final results of the European carvedilol atherectomy restenosis (EUROCARE) trial.
Serruys PW; Foley DP; Höfling B; Puel J; Glogar HD; Seabra-Gomes R; Goicolea J; Coste P; Rutsch W; Katus H; Bonnier H; Wijns W; Betriu A; Hauf-Zachariou U; van Swijndregt EM; Melkert R; Simon R
Circulation; 2000 Apr; 101(13):1512-8. PubMed ID: 10747343
[TBL] [Abstract][Full Text] [Related]
3. Directional coronary atherectomy in 2005.
Repetto A; Ferlini M; Ferrario M; Angoli L; Bramucci E
Ital Heart J; 2005 Jun; 6(6):494-7. PubMed ID: 16008154
[TBL] [Abstract][Full Text] [Related]
4. [Role of atherectomy devices in interventional cardiology].
Dill T; Vom Dahl J
Herz; 2002 Sep; 27(6):502-7. PubMed ID: 12378394
[TBL] [Abstract][Full Text] [Related]
5. Atherectomy (directional, rotational, extractional) and its role in percutaneous revascularization.
Kaufmann UP; Meyer BJ
Curr Opin Cardiol; 1995 Jul; 10(4):412-9. PubMed ID: 7549084
[TBL] [Abstract][Full Text] [Related]
6. Commentary on the Carvedilol or Metoprolol European Trial (COMET).
Poole-Wilson PA
Am J Cardiol; 2004 May; 93(9A):40B-2B. PubMed ID: 15144936
[TBL] [Abstract][Full Text] [Related]
7. [Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomized trial].
Costalunga A; Gavazzi A
Ital Heart J Suppl; 2001 Nov; 2(11):1246-7. PubMed ID: 11775420
[No Abstract] [Full Text] [Related]
8. Role of carvedilol in atrial fibrillation: insights from clinical trials.
Gheorghiade M; Lukas MA
Am J Cardiol; 2004 May; 93(9A):53B-7B. PubMed ID: 15144939
[TBL] [Abstract][Full Text] [Related]
9. Carvedilol improves endothelium-dependent dilatation in patients with coronary artery disease.
Matsuda Y; Akita H; Terashima M; Shiga N; Kanazawa K; Yokoyama M
Am Heart J; 2000 Nov; 140(5):753-9. PubMed ID: 11054621
[TBL] [Abstract][Full Text] [Related]
10. Directional coronary atherectomy: from therapeutic device to research tool in coronary artery disease.
Di Sciascio G; Patti G
Cardiologia; 1999 Apr; 44(4):333-9. PubMed ID: 10371784
[TBL] [Abstract][Full Text] [Related]
11. Pullback atherectomy (PAC) for the treatment of complex bifurcation coronary artery disease.
Fischell TA; Drexler H
Cathet Cardiovasc Diagn; 1996 Jun; 38(2):218-21. PubMed ID: 8776534
[TBL] [Abstract][Full Text] [Related]
12. Beta-blockers in heart failure. Do they improve the quality as well as the quantity of life?
Fowler MB
Eur Heart J; 1998 Dec; 19 Suppl P():P17-25. PubMed ID: 9886708
[TBL] [Abstract][Full Text] [Related]
13. Pullback atherectomy with the Arrow-Fischell atherectomy device.
Webb J; Carere R; Lau E; Rabinowitz A; Dodek A
Cathet Cardiovasc Diagn; 1997 Sep; 42(1):79-83. PubMed ID: 9286549
[TBL] [Abstract][Full Text] [Related]
14. Carvedilol for heart failure: more than just a beta-blocker?
Cleland JG
Br J Hosp Med; 1997 Nov 19-Dec 9; 58(10):493-7. PubMed ID: 10193451
[TBL] [Abstract][Full Text] [Related]
15. [Severe heart failure. Carvedilol lowers mortality].
MMW Fortschr Med; 2001 Mar; 143(9):58. PubMed ID: 11288541
[No Abstract] [Full Text] [Related]
16. Landmark studies: the Australia/New Zealand Heart Failure Collaborative Group (ANZ) Trial and the US Carvedilol Trials Program.
Gilbert EM
Am J Cardiol; 2004 May; 93(9A):30B-4B. PubMed ID: 15144934
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of randomized trials of percutaneous transluminal coronary angioplasty versus atherectomy, cutting balloon atherotomy, or laser angioplasty.
Bittl JA; Chew DP; Topol EJ; Kong DF; Califf RM
J Am Coll Cardiol; 2004 Mar; 43(6):936-42. PubMed ID: 15028347
[TBL] [Abstract][Full Text] [Related]
18. Carvedilol following AMI.
Herner SJ; Seaton TL
J Fam Pract; 1997 Oct; 45(4):288-9. PubMed ID: 9379146
[No Abstract] [Full Text] [Related]
19. New evidence from the CAPRICORN Trial: the role of carvedilol in high-risk, post-myocardial infarction patients.
Sackner-Bernstein JD
Rev Cardiovasc Med; 2003; 4 Suppl 3():S25-9. PubMed ID: 14564231
[TBL] [Abstract][Full Text] [Related]
20. Guiding catheters for directional coronary atherectomy.
Whitlow PL
Cathet Cardiovasc Diagn; 1993; Suppl 1():72-5. PubMed ID: 8324820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
